Jiudian Pharmaceutical adheres to research and development as the driving force, and has built two research and development systems. The Pharmaceutical Research Institute is responsible for the research and development of difficult generic drugs, improved new drugs and innovative drugs, and Putao Pharmaceutical is committed to providing generic drugs and consistency evaluation technical services for enterprises and customers in the same industry.

Jiudian Pharmaceutical is a national high-tech enterprise, in recent years, the proportion of R & D investment in revenue is stable at more than 8%, with more than 10,000 square meters of first-class R & D laboratory, more than 200 sets of high performance liquid chromatography and ion chromatograph and other large instruments and equipment. With doctors, masters and overseas returnees as the backbone, the company has set up a research and development team of more than 430 people, and has built innovation platforms such as National enterprise Technology Center, postdoctoral research workstation, Hunan Engineering Research Center for new gel Paste and Hunan Respiratory Drug Engineering Technology Research Center.

In recent years, Jiudian Pharmaceutical has undertaken national major new drug development projects, national high-tech industrialization key projects, national high-tech industrialization projects, the Ministry of Science and Technology Innovation Fund and other national scientific research projects, and won 18 provincial and municipal science and technology progress awards. By the end of 2023, the company has a total of 118 drug registration certificates, of which 24 have passed the consistency evaluation; The registration of nearly 170 raw materials and pharmaceutical excipients has been completed, of which 103 have been transferred to type A; Currently, the company has a total of 130 patents, including 51 invention patents.